Trials / Unknown
UnknownNCT04835324
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 650 (actual)
- Sponsor
- Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, retrospective, real-world study. The purpose of this study is to observe the effectiveness and safety of regorafenib in Chinese advanced colorectal cancer patients. The main observational goals include overall survival(OS), 6 month OS rate, 1 year OS rate, and treatment time failure (TTF), other study goals include objective response rate( ORR)、Disease control rate（DCR）and adverse event(AE) of regorafenib.
Conditions
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2022-02-01
- Completion
- 2022-10-01
- First posted
- 2021-04-08
- Last updated
- 2022-03-11
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04835324. Inclusion in this directory is not an endorsement.